当前位置:首页 - 行情中心 - 圣湘生物(688289) - 财务分析 - 现金流量表

圣湘生物

(688289)

  

流通市值:86.36亿  总市值:86.36亿
流通股本:5.75亿   总股本:5.75亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,334,492,006.86879,195,607.07417,204,958.571,750,017,306.76
  收到的税费返还667,436.45554,729.47541,198.2118,446,837.8
  收到其他与经营活动有关的现金42,297,197.724,876,518.7715,031,906.56133,711,848.65
  经营活动现金流入小计1,377,456,641.01904,626,855.31432,778,063.341,902,175,993.21
  购买商品、接受劳务支付的现金439,830,163.91276,849,477.93124,344,007.69416,825,477.31
  支付给职工以及为职工支付的现金394,914,020.56268,249,401.91148,205,336.6545,985,597.64
  支付的各项税费83,507,593.3761,382,293.2525,261,000.42108,801,844.63
  支付其他与经营活动有关的现金488,243,538.82313,802,138.79135,932,106.78646,602,229.93
  经营活动现金流出小计1,406,495,316.66920,283,311.88433,742,451.491,718,215,149.51
  经营活动产生的现金流量净额-29,038,675.65-15,656,456.57-964,388.15183,960,843.7
二、投资活动产生的现金流量:
  收回投资收到的现金286,391,403.67184,025,370.4424,650,759.23841,044,150
  取得投资收益收到的现金2,304,679.411,896,555.26298,822.986,457,386.12
  处置固定资产、无形资产和其他长期资产收回的现金净额135,464.32125,476.12333,032.952,444,806.47
  收到的其他与投资活动有关的现金884,958.2---
  投资活动现金流入小计289,716,505.6186,047,401.8225,282,615.16849,946,342.59
  购建固定资产、无形资产和其他长期资产支付的现金153,129,914.67108,942,063.759,150,764.9369,767,235.79
  投资支付的现金626,683,229.53516,969,256.93213,000,0001,050,900,000.01
  取得子公司及其他营业单位支付的现金---715,472,815.24
  投资活动现金流出小计779,813,144.2625,911,320.63272,150,764.92,136,140,051.04
  投资活动产生的现金流量净额-490,096,638.6-439,863,918.81-246,868,149.74-1,286,193,708.45
三、筹资活动产生的现金流量:
  吸收投资收到的现金49,062,00022,500,000-11,782,633.12
  其中:子公司吸收少数股东投资收到的现金49,062,000---
  取得借款收到的现金506,301,911.55496,301,911.5577,128,870.151,106,611,084.19
  收到其他与筹资活动有关的现金957,682.23774,000--
  筹资活动现金流入小计556,321,593.78519,575,911.5577,128,870.151,118,393,717.31
  偿还债务支付的现金118,219,27592,419,27528,400,000403,130,000
  分配股利、利润或偿付利息支付的现金171,644,719.02164,612,988.477,562,599.07333,680,980.05
  支付其他与筹资活动有关的现金102,202,276.867,704,129.2775,322.647,205,321.89
  筹资活动现金流出小计392,066,270.82324,736,392.7436,037,921.71744,016,301.94
  筹资活动产生的现金流量净额164,255,322.96194,839,518.8141,090,948.44374,377,415.37
四、汇率变动对现金及现金等价物的影响-9,921,094.75-7,492,158.87-3,987,574.39-2,230,122.3
五、现金及现金等价物净增加额-364,801,086.04-268,173,015.44-210,729,163.84-730,085,571.68
  加:期初现金及现金等价物余额3,746,542,445.243,746,542,445.243,746,542,445.244,476,628,016.92
  期末现金及现金等价物余额3,381,741,359.23,478,369,429.83,535,813,281.43,746,542,445.24
补充资料:
  净利润-81,309,407.96-153,924,782.58
  资产减值准备--2,026,154.58-29,650,010
  固定资产和投资性房地产折旧-85,206,966.75-154,481,319.39
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-85,206,966.75-154,481,319.39
  无形资产摊销-31,873,584.43-49,298,222.76
  长期待摊费用摊销-8,501,531.21-19,436,185.68
  处置固定资产、无形资产和其他长期资产的损失-11,433,901.15-2,946,565.51
  固定资产报废损失-8,020,639.9-2,413,387.46
  公允价值变动损失--78,896,970.38--48,574,301.3
  财务费用--12,971,977.75-24,125,374.74
  投资损失-14,113,137.14-55,237,813
  递延所得税--2,541.28--9,324,476.39
  其中:递延所得税资产减少--8,086,486.12--12,363,823.8
    递延所得税负债增加-8,083,944.84-3,039,347.41
  存货的减少--19,188,434.34--10,311,104.98
  经营性应收项目的减少--65,199,035.83--39,973,098.07
  经营性应付项目的增加--3,523,202.54--110,126,284.26
  其他--67,962,223.36--129,039,885.16
  现金的期末余额-3,478,369,429.8-3,746,542,445.24
  减:现金的期初余额-3,746,542,445.24-4,476,628,016.92
  现金及现金等价物的净增加额--268,173,015.44--730,085,571.68
公告日期2026-10-292026-08-272026-04-302026-04-30
审计意见(境内)标准无保留意见
TOP↑